5 May 2021
At the meeting of 7 April 2021 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| inguinal hernia | 47/2021 | 48/2021 |
| open-angle glaucoma | 49/2021 | 50/2021 |
| endometriosis | 51/2021 | 52/2021 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined Amendment Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| cerebrovascular accident | 53/2021 | 54/2021 |
| ischaemic heart disease | 55/2021 | 56/2021 |
| Guillain-Barre syndrome | 57/2021 | 58/2021 |
The above SOPs take effect from 24 May 2021.
Summary of Changes
Decided to Undertake Consultation regarding:
| Condition | Reasons for Decision | Date for Final Decision |
|---|---|---|
| myeloma | Intention to remove one or more factors | July 2021 |
| carpal tunnel syndrome | Intention to remove one or more factors | July 2021 |
Finalised Declaration for:
| Condition | Declaration | Reasons for Decision |
|---|---|---|
| malignant neoplasm of the breast |
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- inguinal hernia
- open-angle glaucoma
- endometriosis
- cerebrovascular accident (focussed review - COVID-19 sequelae)
- ischaemic heart disease (focussed review - COVID-19 sequelae)
- Guillain-Barre syndrome (focussed review - COVID-19 sequelae)
- malignant neoplasm of the breast (focussed review - combined hormonal contraceptives)
New Investigations
Decided to advertise the following investigations:
- allergic rhinitis
- giant cell arteritis (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- inflammatory bowel disease (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- malignant neoplasm of the cervix (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- malignant neoplasm of the kidney (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- non-aneurysmal aortic atherosclerotic disease (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- peripheral artery disease (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- psoriasis (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- pulmonary thromboembolism (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- renal artery atherosclerotic disease (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- retinal vascular occlusion (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- diabetes mellitus (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- deep vein thrombosis (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- chronic pancreatitis (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- narcolepsy
- periodic limb movement disorder
- restless legs syndrome
- somatic symptom disorder
- acute lymphoblastic leukaemia/lymphoblastic lymphoma (focussed review - definition of 8-hour time-weighted average (TWA))
- ankylosing spondylitis (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- anosmia (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- aortic aneurysm and aortic wall disorders (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- asthma (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- carotid artery disease (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
- tinnitus (focussed review - definition of 'pack year of tobacco products' and 'pack-year')
The above declaration and investigation notices appear in the Government Notices Gazette of 4 May 2021.